Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Resources Double-Crane Benxi Pharmaceutical, formerly known as Liaoning Benxi No. 3 Pharmaceutical Factory, is a pharmaceutical manufacturing company based in Benxi, China. As a subsidiary of China Resources Double-Crane Pharmaceutical, the company specializes in the production of chemical drugs and traditional Chinese medicine (TCM) preparations. Its core therapeutic focus includes cardiovascular health, cerebrovascular diseases, and hepatology. The company operates multiple GMP-certified production lines for tablets, capsules, and granules, and is well-known for its liver-supportive treatments and anti-hypertensive medications. It plays a significant role in the regional pharmaceutical industrial cluster in Liaoning province.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Liaoning Benxi No. 3 Pharmaceutical Company.